CTHRC 1 Derived From Cancer‐Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF ‐ STAT 3 Pathway
Cancer Medicine · 2025
DOI: 10.1002/cam4.71126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Hang Yin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Pancreatic Neoplasms, Cancer-Associated Fibroblasts, Extracellular Matrix Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nanjing Health Science and Technology Development Special Project.
Abstract (Originalsprache)
Background
Collagen triple helix repeat containing 1 (CTHRC1) is a secreted protein involved in tissue remodeling and fibrotic processes, which also suggests emerging roles in cancer. Studies have shown that it is mainly expressed in the outer membrane fibroblasts of injured arteries and in the neointimal smooth muscle cells, where it promotes cell migration and tissue damage repair. However, the regulatory role of CTHRC1 as a tumor microenvironment factor in pancreatic cancer is not well understood.
Methods
We employed multi‐omics analysis combined with cellular and animal experiments to examine the association between CTHRC1 and the LIF/STAT3 pathway in pancreatic cancer clinical specimens. Using AsPC‐1/PANC‐1 and other cell lines, we conducted proliferation, migration, invasion, and signaling pathway studies, and elucidated the regulatory mechanism of CTHRC1 through genetic interventions and STAT3 inhibitors.
Results
In this study, we found that CTHRC1 is highly expressed in the cancer‐associated fibroblasts (CAFs) of pancreatic cancer and is associated with poor prognosis in patients. Functionally, we observed that CTHRC1 in CAFs promotes the proliferation, migration, and invasion of pancreatic cancer cells both in vitro and in vivo. In mechanistic studies, RNA sequencing revealed that CTHRC1 promotes the proliferation and migration of pancreatic cancer cells through the LIF‐mediated STAT3 axis.
Conclusion
These findings reveal the role of CTHRC1 in CAFs in pancreatic cancer, suggesting that it is an attractive therapeutic target and tumor marker. This study uncovers the biological mechanism of CTHRC1 in CAFs in pancreatic cancer, providing new strategies for the treatment of pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanjing Medical University, Nanjing, China.
- Department of General Surgery, Nantong Hospital of Traditional Chinese Medicine, Nantong Hospital Affiliated to Nanjing University of Chinese Medicine, Nantong, China.
- Department of General Surgery, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.
- Department of General Surgery, Jianghan University Affiliated Hospital (Wuhan Sixth Hospital), Wuhan, China.
ORCID-Profile: Hang Yin
Förderung
- Nanjing Health Science and Technology Development Special Project
Zitieren
APA
Yin, H., Pan, Y., Li, Z., Liu, Y., Chen, J., Chen, X., Zhang, C., Zhu, F., & Yu, C. (2025). CTHRC 1 Derived From Cancer‐Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF ‐ STAT 3 Pathway. Cancer Medicine. https://doi.org/10.1002/cam4.71126
Vancouver
Yin H, Pan Y, Li Z, Liu Y, Chen J, Chen X, et al. CTHRC 1 Derived From Cancer‐Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF ‐ STAT 3 Pathway. Cancer Medicine. 2025. doi:10.1002/cam4.71126
BibTeX
@article{Yin2025,
author = {Yin, Hang and Pan, Yue and Li, Zhuang and Liu, Yong and Chen, Jiatong and Chen, Xin and Zhang, Chengfei and Zhu, Feng and Yu, Chunzhao},
title = {CTHRC 1 Derived From Cancer‐Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF ‐ STAT 3 Pathway},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71126}
}
EUVIMED